A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms
Clinical trial NCT01052103 · COMPLETED
Trial details
- NCT number
- NCT01052103
- Sponsor
- Denovo Biopharma LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-01
- Primary completion
- 2012-06-01
- Enrollment
- 167
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.